Amphetamine use and co-occurring psychological problems

There has been a substantial increase in the use of amphetamine in Australia in recent years, with many users presenting with a range of psychological symptoms including those associated with mood, anxiety and psychotic disorders. Many of these symptoms are due to the direct effect of amphetamine or occur during withdrawal and resolve rapidly. However, determining whether there is a pre-existing disorder requires a careful assessment of the temporal relationship between the onset of regular drug use and symptoms, and ideally ongoing monitoring of symptoms in the absence of drug use. Treatment options need to match the diagnostic presentation, and drawing from the limited literature in this area it is recommended that amphetamine use be targeted in the first instance and other more intensive treatments follow as the diagnostic picture becomes clearer. Many people use psychostimulants and, although the majority who use occasionally by non-injecting routes of administration do not experience problems (Hall, Darke, Ross, & Wodak, 1993 Hall, W , Darke, S , Ross, M , and Wodak, A , 1993. Patterns of drug use and risk-taking among injecting amphetamine and opioid drug users in Sydney, Australia , Addiction 88 (1993), pp. 509–516.[Crossref], [Web of Science ®] , [Google Scholar]), it appears that as many as 30% of amphetamine users develop a psychostimulant use disorder (Hall, Teesson, Lynskey, & Degenhardt, 1998 Hall, W , Tesson, M , Lynskey, M , and Degenhardt, L , 1998. " The prevalence in the past year of substance use and ICD-10 substance use disorders in Australian adults: Findings from the National Survey of Mental Health and Well-Being ". 1998, (NDARC Technical Report No.63), Sydney: NDARC. [Google Scholar]). Of particular concern is the recent increase in the use of methamphetamine across Australia (Topp, Day, & Degenhardt, 2003 Topp, L , Day, C , and Degenhardt, L , 2003. Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia , Drug and Alcohol Dependence 70 (2003), pp. 275–286.[Crossref], [Web of Science ®] , [Google Scholar]), a synthetic drug closely related to amphetamine but with higher abuse potential. It produces euphoric effects that are similar to, but longer lasting than those of, cocaine (Dean, 2004 Dean, A , 2004. "Pharmacology of psychostimulants". 2004. p. pp. 35 – 50), In: A. Baker, N. K. Lee, & L. Jenner (Eds.), Towards better interventions and care for psychostimulant users (2nd ed, Canberra: Commonwealth of Australia. [Google Scholar]), with some evidence suggesting that the progression from initial use to regular and problematic use occurs more rapidly than with cocaine use (Castro, Barrington, Walton, & Rawson, 2000 Castro, FG , Barrington, EH , Walton, MA , and Rawson, RA , 2000. Cocaine and methamphetamine: Differential addiction rates , Psychology of Addictive Behaviors 14 (2000), pp. 390–396.[Crossref] , [Google Scholar]). There are many indications (e.g., increased availability of methamphetamine, an increasing trend towards injection, an increase in demand for treatment and reports of additional demands for emergency services) that the increase in methamphetamine use in Australia in the last 5 years will continue (Jenner & McKetin, 2004 Jenner, L , and McKetin, R , 2004. "Prevalence and patterns of psychostimulants". 2004. p. (pp. 63 – 84), In: A. Baker, N. Lee & L. Jenner (Eds), Models of intervention and care for psychostimulant users (2nd Ed) National Drug Strategy Monograph Series No. 51, Canberra: Commonwealth of Australia. [Google Scholar]). There are now a number of studies in which the range of psychological symptoms have been documented among amphetamine users including depressed mood, anxiety, irritability, paranoia, mood swings, difficulty concentrating, aggression, hallucinations and psychosis (Topp et al., 2003 Topp, L , Day, C , and Degenhardt, L , 2003. Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia , Drug and Alcohol Dependence 70 (2003), pp. 275–286.[Crossref], [Web of Science ®] , [Google Scholar]). It would appear that many of these symptoms are related to the use of amphetamine and abate on cessation of use. Cross-sectional studies have suggested that perhaps up to half of regular amphetamine users report that these symptoms emerge after the commencement of regular amphetamine use (Baker et al., submitted; Hall, Hando, Darke, & Ross, 1996 Hall, W , Hando, J , Darke, S , and Ross, J , 1996. Psychological morbidity and route of administration among amphetamine users in Sydney, Australia , Addiction 91 (1996), pp. 81–87.[Crossref], [Web of Science ®] , [Google Scholar]). However, it is possible that some symptoms may have pre-dated the use of amphetamine and may be related to the initial use of the substance. The risk of experiencing adverse effects of amphetamine appears to be related to dose, with the risk of harm reduced with less than twice weekly use and the use of small amounts (Hall & Hando, 1994 Hall, W , and Hando, J , 1994. Route of administration and adverse effects of amphetamine use among young adults in Sydney, Australia , Drug and Alcohol Review 13 (1994), pp. 277–284.[Taylor & Francis Online] , [Google Scholar]). In this paper we review the literature describing the prevalence and course of the most common co-occurring psychological problems among amphetamine users. A review of treatments currently considered to be best practice will be provided and recommendations for further research suggested

Addiction · Amphetamine · Anxiety · Drug · Mental health · Mood · Mood disorders · Psychiatry · Substance use · Clinical Psychology · HIV, Drug Use, Sexual Risk · Medicine · Opioid Use Disorder Treatment · Psychology · Substance Abuse Treatment and Outcomes

• A comparison of methamphetamine and nonmethamphetamine users in a dual diagnosis facility

  Valerie M Gonsalves, Jessica L Sapp et al.•Addiction Research & Theory•2007

  Add to list

• Enacting multiple methamphetamines

  Open Access•Robyn Dwyer, David Moore•International Journal of Drug…•2013

  Add to list

• Comparing Mental Health across Distinct Groups of Users of Psychedelics, MDMA, Psychostimulants, and Cannabis

  Ansgar Rougemont-Bücking, Henrik Jungaberle et al.•Journal of Psychoactive Drugs•2019

  Add to list

• Methamphetamine and Cocaine Users

  Richard Rawson, Richard A Rawson et al.•Journal of Psychoactive Drugs•2000

  Add to list